October 10, 2024
Snapshot Top 10: Dow Jones U.S. Pharmaceuticals Index



The Top 10 performing stocks in the Dow Jones U.S. Pharmaceuticals Index are shown for seven different investment strategies. Whether you are looking for value, growth or dividend stocks, or you want stocks that rank well overall, you can see the top 10 stock picks, together with how they rank on a scale of 1 to 100 from the perspective of different investment strategies. We have also added our newest Sentiment and 360° View ranks, which encapsulate the market voices of analysts and professional investors into a simple ranking for easily evaluating stocks. As an objective research provider, Obermatt has been refining its stock analysis algorithms for more than 10 years (no AI used here!)

Select any stock for the detailed analysis of that stock's performance across the different investment analyses. Please note that the Top 10 stocks focus only on Large to XX-Large companies.


What the six ranks mean

For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. The higher the rank, the better the stock performs than its peers. And, we do this for six investment strategies:

Value - shows how good of a value the stock is. Green is "inexpensive"; red is "expensive".

Growth - shows a company's growth potential. Green is "high growth" expected; red is "tough times ahead".

Safety - relates to the amount of debt a company has. Green is low debt level; red is high debt level.

Combined Financial - this isn't an average of the first three ranks but rather a consolidated view across several financial indicators. Green = good; red = tread carefully.

(NEW) Sentiment - quantifies professional analyst ratings and holdings as well as market pulse. Green = positive sentiment; red = skepticism (Only available to Premium Subscribers).

(NEW) 360° View - the ultimate rating with all financial and non-financial indicators.

Special Analysis: TOP 10 Dividend Investment Strategy

Many people ask for tips about dividend stocks. These are the Top 10 dividend stocks in the Dow Jones U.S. Pharmaceuticals Index as of October 10, 2024.

TOP 10 Dividend Investment Strategy Value Strategy DIVIDEND Value Strategy VALUE Combined Strategy COMBINED 360° Strategy 360° VIEW
1. Pfizer (XXL, US)  Pharmaceuticals
1. Pfizer (XXL, US)   Pharmaceuticals 100 99 59 67
2. Bristol-Myers Squibb (XXL, US)  Pharmaceuticals
2. Bristol-Myers Squibb (XXL, US)   Pharmaceuticals 98 89 32 23
3. Johnson & Johnson (XXL, US)  Pharmaceuticals
3. Johnson & Johnson (XXL, US)   Pharmaceuticals 94 57 49 40
4. Phibro Animal (L, US)  Pharmaceuticals
4. Phibro Animal (L, US)   Pharmaceuticals 92 99 100 85
5. Merck & Co. (XXL, US)  Pharmaceuticals
5. Merck & Co. (XXL, US)   Pharmaceuticals 90 75 83 85
6. Zoetis (XL, US)  Pharmaceuticals
6. Zoetis (XL, US)   Pharmaceuticals 86 17 23 50
7. Eli Lilly (XXL, US)  Pharmaceuticals
7. Eli Lilly (XXL, US)   Pharmaceuticals 86 17 41 56

This company has a special achievement which is documented on its stock research page.

October 10, 2024. Top 10s are published weekly following the . ( or for more stocks)


D.J. US Pharmaceutical Top 10: Obermatt 360° Investment Strategy

TOP 10 Obermatt 360° Investment Strategy 360° Strategy 360° VIEW Value Strategy VALUE Combined Strategy COMBINED Sentiment Strategy SENTIMENT
1. Assertio Therapeutics (S, US)   Pharmaceuticals
1. Assertio Therapeutics (S, US)   Pharmaceuticals 92 73 100 43
2. Merck & Co. (XXL, US)   Pharmaceuticals
2. Merck & Co. (XXL, US)   Pharmaceuticals 85 75 83 71
3. Phibro Animal (L, US)   Pharmaceuticals
3. Phibro Animal (L, US)   Pharmaceuticals 85 99 100 5
4. Amphastar (M, US)   Pharmaceuticals
4. Amphastar (M, US)   Pharmaceuticals 74 31 61 85
5. Prestige (L, US)   Pharmaceuticals
5. Prestige (L, US)   Pharmaceuticals 74 53 43 100
6. Pfizer (XXL, US)   Pharmaceuticals
6. Pfizer (XXL, US)   Pharmaceuticals 67 99 59 63
7. Eli Lilly (XXL, US)   Pharmaceuticals
7. Eli Lilly (XXL, US)   Pharmaceuticals 56 17 41 77
8. Zoetis (XL, US)   Pharmaceuticals
8. Zoetis (XL, US)   Pharmaceuticals 50 17 23 93
9. Pacira BioSciences (M, US)   Pharmaceuticals
9. Pacira BioSciences (M, US)   Pharmaceuticals 45 91 78 21
10. Johnson & Johnson (XXL, US)   Pharmaceuticals
10. Johnson & Johnson (XXL, US)   Pharmaceuticals 40 57 49 47

October 10, 2024. Top 10s are published weekly following the . ( or for more stocks)


D.J. US Pharmaceutical Top 10: Sentiment Investment Strategy

TOP 10 Sentiment Investment Strategy Sentiment Strategy SENTIMENT Value Strategy VALUE Combined Strategy COMBINED 360° Strategy 360° VIEW
1. Prestige (L, US)   Pharmaceuticals
1. Prestige (L, US)   Pharmaceuticals 100 53 43 74
2. Zoetis (XL, US)   Pharmaceuticals
2. Zoetis (XL, US)   Pharmaceuticals 93 17 23 50
3. Amphastar (M, US)   Pharmaceuticals
3. Amphastar (M, US)   Pharmaceuticals 85 31 61 74
4. Eli Lilly (XXL, US)   Pharmaceuticals
4. Eli Lilly (XXL, US)   Pharmaceuticals 77 17 41 56
5. Merck & Co. (XXL, US)   Pharmaceuticals
5. Merck & Co. (XXL, US)   Pharmaceuticals 71 75 83 85
6. Pfizer (XXL, US)   Pharmaceuticals
6. Pfizer (XXL, US)   Pharmaceuticals 63 99 59 67
7. Johnson & Johnson (XXL, US)   Pharmaceuticals
7. Johnson & Johnson (XXL, US)   Pharmaceuticals 47 57 49 40
8. Assertio Therapeutics (S, US)   Pharmaceuticals
8. Assertio Therapeutics (S, US)   Pharmaceuticals 43 73 100 92
9. Bristol-Myers Squibb (XXL, US)   Pharmaceuticals
9. Bristol-Myers Squibb (XXL, US)   Pharmaceuticals 31 89 32 23

October 10, 2024. Top 10s are published weekly following the . ( or for more stocks)


D.J. US Pharmaceutical Top 10: Value Investment Strategy

TOP 10 Value Investment Strategy Value Strategy VALUE Growth Strategy GROWTH Combined Strategy COMBINED 360° Strategy 360° VIEW
1. Pfizer (XXL, US)   Pharmaceuticals
1. Pfizer (XXL, US)   Pharmaceuticals 99 39 59 67
2. Phibro Animal (L, US)   Pharmaceuticals
2. Phibro Animal (L, US)   Pharmaceuticals 99 63 100 85
3. Pacira BioSciences (M, US)   Pharmaceuticals
3. Pacira BioSciences (M, US)   Pharmaceuticals 91 3 78 45
4. Bristol-Myers Squibb (XXL, US)   Pharmaceuticals
4. Bristol-Myers Squibb (XXL, US)   Pharmaceuticals 89 7 32 23
5. Merck & Co. (XXL, US)   Pharmaceuticals
5. Merck & Co. (XXL, US)   Pharmaceuticals 75 69 83 85
6. Assertio Therapeutics (S, US)   Pharmaceuticals
6. Assertio Therapeutics (S, US)   Pharmaceuticals 73 63 100 92
7. Johnson & Johnson (XXL, US)   Pharmaceuticals
7. Johnson & Johnson (XXL, US)   Pharmaceuticals 57 25 49 40
8. Prestige (L, US)   Pharmaceuticals
8. Prestige (L, US)   Pharmaceuticals 53 43 43 74
9. Amphastar (M, US)   Pharmaceuticals
9. Amphastar (M, US)   Pharmaceuticals 31 69 61 74
10. Supernus Pharma (M, US)   Pharmaceuticals
10. Supernus Pharma (M, US)   Pharmaceuticals 29 9 30 19

October 10, 2024. Top 10s are published weekly following the . ( or for more stocks)


D.J. US Pharmaceutical Top 10: Growth Investment Strategy

TOP 10 Growth Investment Strategy Growth Strategy GROWTH Value Strategy VALUE Combined Strategy COMBINED 360° Strategy 360° VIEW
1. Eli Lilly (XXL, US)   Pharmaceuticals
1. Eli Lilly (XXL, US)   Pharmaceuticals 97 17 41 56
2. Catalent (XL, US)   Pharmaceuticals
2. Catalent (XL, US)   Pharmaceuticals 83 9 12 10
3. Nektar (S, US)   Pharmaceuticals
3. Nektar (S, US)   Pharmaceuticals 79 9 72 34
4. Merck & Co. (XXL, US)   Pharmaceuticals
4. Merck & Co. (XXL, US)   Pharmaceuticals 69 75 83 85
5. Amphastar (M, US)   Pharmaceuticals
5. Amphastar (M, US)   Pharmaceuticals 69 31 61 74
6. Assertio Therapeutics (S, US)   Pharmaceuticals
6. Assertio Therapeutics (S, US)   Pharmaceuticals 63 73 100 92
7. Phibro Animal (L, US)   Pharmaceuticals
7. Phibro Animal (L, US)   Pharmaceuticals 63 99 100 85
8. Zoetis (XL, US)   Pharmaceuticals
8. Zoetis (XL, US)   Pharmaceuticals 61 17 23 50
9. Prestige (L, US)   Pharmaceuticals
9. Prestige (L, US)   Pharmaceuticals 43 53 43 74
10. Pfizer (XXL, US)   Pharmaceuticals
10. Pfizer (XXL, US)   Pharmaceuticals 39 99 59 67

October 10, 2024. Top 10s are published weekly following the . ( or for more stocks)


D.J. US Pharmaceutical Top 10: Safety Investment Strategy

TOP 10 Safety Investment Strategy Safety Strategy SAFETY Value Strategy VALUE Combined Strategy COMBINED 360° Strategy 360° VIEW
1. Supernus Pharma (M, US)  Pharmaceuticals
1. Supernus Pharma (M, US)   Pharmaceuticals 100 29 30 19
2. Assertio Therapeutics (S, US)  Pharmaceuticals
2. Assertio Therapeutics (S, US)   Pharmaceuticals 96 73 100 92
3. Nektar (S, US)  Pharmaceuticals
3. Nektar (S, US)   Pharmaceuticals 94 9 72 34
4. Pacira BioSciences (M, US)  Pharmaceuticals
4. Pacira BioSciences (M, US)   Pharmaceuticals 94 91 78 45
5. Phibro Animal (L, US)  Pharmaceuticals
5. Phibro Animal (L, US)   Pharmaceuticals 88 99 100 85
6. Johnson & Johnson (XXL, US)  Pharmaceuticals
6. Johnson & Johnson (XXL, US)   Pharmaceuticals 70 57 49 40
7. Amphastar (M, US)  Pharmaceuticals
7. Amphastar (M, US)   Pharmaceuticals 67 31 61 74
8. Zoetis (XL, US)  Pharmaceuticals
8. Zoetis (XL, US)   Pharmaceuticals 48 17 23 50
9. Merck & Co. (XXL, US)  Pharmaceuticals
9. Merck & Co. (XXL, US)   Pharmaceuticals 48 75 83 85
10. Prestige (L, US)  Pharmaceuticals
10. Prestige (L, US)   Pharmaceuticals 45 53 43 74

October 10, 2024. Top 10s are published weekly following the . ( or for more stocks)


D.J. US Pharmaceutical Top 10: Combined Investment Strategy

TOP 10 Combined Investment Strategy Combined Strategy COMBINED Value Strategy VALUE Growth Strategy GROWTH 360° Strategy 360° VIEW
1. Assertio Therapeutics (S, US)  Pharmaceuticals
1. Assertio Therapeutics (S, US)   Pharmaceuticals 100 73 63 92
2. Phibro Animal (L, US)  Pharmaceuticals
2. Phibro Animal (L, US)   Pharmaceuticals 100 99 63 85
3. Merck & Co. (XXL, US)  Pharmaceuticals
3. Merck & Co. (XXL, US)   Pharmaceuticals 83 75 69 85
4. Pacira BioSciences (M, US)  Pharmaceuticals
4. Pacira BioSciences (M, US)   Pharmaceuticals 78 91 3 45
5. Nektar (S, US)  Pharmaceuticals
5. Nektar (S, US)   Pharmaceuticals 72 9 79 34
6. Amphastar (M, US)  Pharmaceuticals
6. Amphastar (M, US)   Pharmaceuticals 61 31 69 74
7. Pfizer (XXL, US)  Pharmaceuticals
7. Pfizer (XXL, US)   Pharmaceuticals 59 99 39 67
8. Johnson & Johnson (XXL, US)  Pharmaceuticals
8. Johnson & Johnson (XXL, US)   Pharmaceuticals 49 57 25 40
9. Prestige (L, US)  Pharmaceuticals
9. Prestige (L, US)   Pharmaceuticals 43 53 43 74
10. Eli Lilly (XXL, US)  Pharmaceuticals
10. Eli Lilly (XXL, US)   Pharmaceuticals 41 17 97 56

October 10, 2024. Top 10s are published weekly following the . ( or for more stocks)


This company has a special achievement which is documented on its stock research page.

Top 10 lists may contain fewer than 10 stocks due to Obermatt’s top 10 quality standards.

Top 10 Stocks from the purely fact-based Obermatt Method in the stock index Dow Jones U.S. Pharmaceuticals Index from October 10, 2024.

Top 10 Stock History D.J. US Pharmaceutical



Obermatt Portfolio Performance
We’re so convinced about our research, that we buy our stock tips.
See the performance of the Obermatt portfolio.